Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BMS exercises option for US licence of Prothena’s Alzheimer’s antibody

pharmaceutical-technologyJune 28, 2021

Tag: BMS , AD , PRX005 , tau

PharmaSources Customer Service